Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124942712 | 12494271 | 2 | F | 201404 | 20160629 | 20160623 | 20160707 | EXP | ES-ASTRAZENECA-2016SE67761 | ASTRAZENECA | 568.00 | MON | F | Y | 0.00000 | 20160707 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124942712 | 12494271 | 1 | PS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | U | 21344 | INJECTION | ||||||||
| 124942712 | 12494271 | 2 | SS | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Oral | U | U | 0 | TABLET | ||||||||
| 124942712 | 12494271 | 3 | SS | GROSERELIN | GOSERELIN | 1 | Unknown | U | U | 0 | |||||||||
| 124942712 | 12494271 | 4 | SS | CYCLOSPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 124942712 | 12494271 | 5 | SS | TAXOTERE | DOCETAXEL | 1 | Unknown | U | U | 0 | |||||||||
| 124942712 | 12494271 | 6 | SS | ANTHRACYCLINES | UNSPECIFIED INGREDIENT | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124942712 | 12494271 | 1 | Invasive ductal breast carcinoma |
| 124942712 | 12494271 | 2 | Invasive ductal breast carcinoma |
| 124942712 | 12494271 | 3 | Invasive ductal breast carcinoma |
| 124942712 | 12494271 | 4 | Invasive ductal breast carcinoma |
| 124942712 | 12494271 | 5 | Invasive ductal breast carcinoma |
| 124942712 | 12494271 | 6 | Invasive ductal breast carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124942712 | 12494271 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124942712 | 12494271 | Malignant neoplasm progression | |
| 124942712 | 12494271 | Therapy partial responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124942712 | 12494271 | 1 | 201602 | 0 | ||
| 124942712 | 12494271 | 4 | 201104 | 0 | ||
| 124942712 | 12494271 | 6 | 201104 | 0 |